ArticleArchives of gynecology and obstetrics2026
Financial distress among women with advanced or metastatic breast cancer in Germany: secondary analysis of prospective ePROCOM data of a two-center cohort.
Article in Archives of gynecology and obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
key messageIn this study, half of all female patients with advanced and metastatic breast cancer reported experiencing financial difficulties. This highlights the need for gynecology and oncology specialists to also address patients' socio-medical needs. Electronic patient-reported outcomes (ePRO) must be used to identify such areas of concern. PURPOSE: The aim was to investigate whether and to what extent female patients with advanced or metastatic breast cancer who are undergoing chemotherapy report financial difficulties due to their physical condition and/or the effects of medical treatment in relation to the German reference cohort.
methodsA secondary data analysis was performed using data collected prospectively as part of the ePROCOM study. A total of n = 168 female patients who had answered questions regarding financial implications of the EORTC QLQ-C30 questionnaire were included in the analysis. Unpaired t tests (Welch) and Chi-square tests as well as multiple regressions were conducted. A bilateral p value of < 0.05 was considered statistically significant in all analyses (alpha = 0.05).
resultsThe prevalence of financial distress was 50.0% (95%-CI 42.4%; 57.6%), defined as a response of at least 2 ("a little") on a 4-point Likert scale. Between the reference cohort scored 4.8 and the breast cancer cohort scored 28.8, there was a significant difference of 24 ± 5.19 score points (p < 0.001; 95%-CI 18.81, 29.19) in financial burden. Overall, the regression model explained 27.7% of the total variance in financial burden through HRQoL, age, and civil status (R
conclusionWomen with advanced or metastatic breast cancer reported substantially higher financial burden than the female German reference population. Lower HRQoL, younger age, and living alone were associated with greater financial impact. These findings support routine assessment of financial distress in those patients and suggest that ePRO-based screening may help identify patients in need of early social-medical support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.